Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Studies on the Biotransformations and Biodistributions of Metal-based Drugs by X-ray absorption spectroscopy (XAS) (CAT#: STEM-ST-0269-WXH)

Introduction

Catalytic metal-based drugs can be broadly divided into two main categories, i.e. those that mimic the catalytic processes of naturally occurring metalloenzymes, and those which contain non-essential metals and/or catalyze abiotic transformations for which there are no enzymatic counterparts.




Principle

X-ray spectroscopy works on the principle of the excitation of core electrons that are orbiting in the lower shell(s). As the electron absorbs x-rays, it becomes excited and jumps to a higher level. The X-ray region used ranges from 1 to 100 nm. When x-rays interact with electrons it excites electrons to the higher levels. Energy absorbed by the electrons has a characteristic value for each element one can distinguish with the X-ray absorption spectrum.
X-ray absorption spectroscopy (XAS) is the measurement of transitions from core electronic states of the metal to the excited electronic states (LUMO) and the continuum; the former is known as X-ray absorption near-edge structure (XANES), and the latter as extended X-ray absorption fine structure (EXAFS) which studies the fine structure in the absorption at energies greater than the threshold for electron release. These two methods give complementary structural information, the XANES spectra reporting electronic structure and symmetry of the metal site, and the EXAFS reporting numbers, types, and distances to ligands and neighboring atoms from the absorbing element

Applications

X-ray absorption spectroscopy (XAS) is a widely used technique for determining the local geometric and/or electronic structure of matter.

Materials

• X-ray generating equipment (X-ray tube)
• Collimators
• Monochromators
• X-ray detectors
Advertisement